Wolverine Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Wolverine Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-67,200	Closed	-$860K	–	1814
2017 Q4	$860K	Buy	67,200 +57,200	+572%	+$651K	0.01%	775
2017 Q3	$123K	Buy	+10,000	New	+$92.9K	﹤0.01%	1069
2017 Q2	–	Sell	-19,000	Closed	-$169K	–	1513
2017 Q1	$169K	Buy	+19,000	New	+$202K	﹤0.01%	877
2016 Q1	–	Sell	-50	Closed	-$1K	–	1756
2015 Q4	$1K	Hold	50	–	–	﹤0.01%	1653
2015 Q3	$5K	Hold	50	–	–	﹤0.01%	1648
2015 Q2	$17K	Sell	50 -845	-94%	-$6.24K	﹤0.01%	1521
2015 Q1	$78K	Buy	+895	New	+$6.37K	﹤0.01%	1148

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Wolverine Asset Management's ARRY Position: Q3 2019 in Review

Wolverine Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 82,346 shares — an estimated $3.81M sold.

Wolverine Asset Management first reported a position in ARRY in Q4 2018 and held it in 2 quarters. The position peaked at $3.81M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Wolverine Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Wolverine Asset Management sold 82,346 Array Biopharma Inc shares in Q3 2019, an estimated $3.81M.
Wolverine Asset Management first reported a position in Array Biopharma Inc in Q4 2018 and held it in 2 quarters.
Wolverine Asset Management's Array Biopharma Inc position peaked at $3.81M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Wolverine Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.